ADVB (Advanced Biomed Corp) Pangali Forward P/E
Relocating assets to the US protects the Taiwanese developer Advanced Biomed Inc (ADVB) from regional conflicts. The expected P/E multiple for Advanced Biomed Inc (ADVB) reflects market expectations, where the value of 0.00 corresponds to the current metric. Business stability is limited by early-stage R&D and a reliance on secondary offerings. Meanwhile, the accuracy of cancer diagnostics is ensured through strict adherence to transportation conditions for high-tech reagents.
Ringkesan rincian data analitis Advanced Biomed Corp (ADVB)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Advanced Biomed Inc|ADVB - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Advanced Biomed Inc|ADVB - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Advanced Biomed Inc.|ADVB - Tanggungan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Advanced Biomed|Rasio cepet advanbiomed.com
- rincian asil keuangan lan kelipatan valuasi:
ADVB - Bathi resik|Bathi sing dikarepake Advanced Biomed Inc|ADVB - Pangali rega marang bathi|Pangali Forward P/E Advanced Biomed Inc|ADVB - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Advanced Biomed Inc.|ADVB - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Advanced Biomed|ADVB - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan advanbiomed.com|ADVB - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Advanced Biomed Inc
Analisis komprehensif perusahaan:Advanced Biomed
The forward P/E determines the market value of a stock relative to expected earnings per share, allowing an investor to assess the extent of the premium paid for potential business growth. Advanced Biomed Inc (ADVB) investments in a highly qualified staff for cancer diagnostics generate future revenues, which is reflected in the company's forward price-to-earnings ratio on GURU.Markets, helping to differentiate the fundamental value of assets from temporary speculative fluctuations.
Karo sapa Advanced Biomed Inc saingan
Prakiraan rega marang bathi ONC (BeiGene)|HALO (Halozyme Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (RevMed)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Therapeutics (BCAX) - Rega marang bathi mangsa ngarep|Personalis Inc - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Corp DCTH|Pangali Forward P/E YMAB|Pangali Forward P/E aurabiosciences.com (AURA)|Pangali Forward P/E CADL (Candel Therapeutics, Inc.)|ARAY: Rasio rega marang bathi mangsa ngarep|SLS: Prakiraan rega marang bathi|ACTU: Rega marang bathi mangsa ngarep|CTOR: Pangali Forward P/E|TuHURA Biosciences (HURA) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Protara Therapeutics, Inc.|Rasio rega marang bathi mangsa ngarep FATE (Fate Therapeutics Inc)|Pangali Forward P/E WHWK|Prakiraan rega marang bathi tscan.com TCRX|Pangali Forward P/E CSBR (Champions Oncology, Inc.)|XBiotech Inc (XBIT) - Rasio prakiraan rega marang bathi|CEL-SCI Corp - Pangali Forward P/E|OSTX (OS Therapies Inc.) - Rasio rega marang bathi mangsa ngarep|RADX (Radiopharm Theranostics Limited) - Prakiraan rega marang bathi|Artiva Biotherapeutics - Pangali mangsa ngarep rega marang bathi|ANL (Adlai Nortye Ltd) - Pangali Forward P/E|Rega marang bathi mangsa ngarep VERU|Pangali Forward P/E TPST|Kapitalisasi marang proyeksi bathi xiliotx.com|Rega marang bathi mangsa ngarep Renovaro RENB|Mural Oncology PLC (MURA) - Rasio prakiraan rega marang bathi|KAPA - Rega marang bathi mangsa ngarep|OnKure Therapeutics Inc (OKUR) - Prakiraan rega marang bathi|GDTC: Pangali Forward P/E|Rasio prakiraan rega marang bathi Curis (CRIS)|APLM (Apollomics Inc.) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep THAR (Tharimmune Corporation)|Prakiraan rega marang bathi GNPX (Genprex, Inc.)|CLDI (calidibio.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E SBFM (Sunshine Biopharma, Inc.)|Kapitalisasi marang proyeksi bathi Xenetic Biosciences Inc. (XBIO)|SLRX - Rega marang bathi mangsa ngarep|PPBT (Kitov Pharma) - Rasio rega marang bathi mangsa ngarep|AONC: Pangali Forward P/E|Prakiraan rega marang bathi beigene.com|CKPT (Checkpoint Therapeutics, Inc.) - Pangali Forward P/E|Pangali Forward P/E elevationoncology.com|Pangali Forward P/E ICAD|ikenaoncology.com - Rasio rega marang bathi mangsa ngarep|Notable Labs, Ltd. - Prakiraan rega marang bathi|Viracta Therapeutics Inc. - Rega marang bathi mangsa ngarep|MorphoSys - Pangali Forward P/E|NAYA: Rega marang bathi mangsa ngarep|AAPGV: Pangali Forward P/E
